Close X
Monday, December 2, 2024
ADVT 
International

Pakistan will have the highest inflation rate in Asia

Darpan News Desk IANS, 21 Sep, 2023 11:46 AM
  • Pakistan will have the highest inflation rate in Asia

New Delhi, Sep 21 (IANS) Pakistan’s economy stands out as an outlier in Asia, according to a new report that predicts the country will have the highest inflation rate but the fourth lowest economic growth rate among all 46 economies in the region, a media report said.

The Asia Development Outlook, the flagship publication of the Asian Development Bank (ADB), has slightly revised downward the economic growth forecast to 1.9 per cent, but it has significantly increased the inflation projection to 25 per cent for the current fiscal year, The Express Tribune reported.

The report anticipates further increases in interest rates and calls for a fiscal consolidation plan that includes limited spending on defence and energy subsidies.

The report also points out that while the currencies of developing economies in Asia have marginally depreciated, Pakistan’s currency has seen a steep devaluation of 30%. Unlike other regional economies, Pakistan saw a decline in foreign remittances, The Express Tribune reported.

The ADB notes that there are exceptionally high downside risks to Pakistan’s economic outlook.

Previously, Pakistan’s economic outlook was relatively poor only within the South Asia region, but continued deterioration in economic conditions has placed the country near the bottom of Asia, The Express Tribune reported.

The report projects that “for FY2024, inflation is forecast at 25 per cent, sharply higher than the earlier 15 per cent projection".

This inflation rate is far higher than the target range set by the central bank and much higher than the target. It represents the highest inflation rate in Asia, significantly exceeding the projected 10 per cent for any other economy”.

The report emphasises that regional currencies have depreciated only marginally so far this year, by 3.7 per cent on a GDP-weighted average basis against the US dollar. However, Pakistan’s currency experienced a significant 30 per cent devaluation since January, The Express Tribune reported.

MORE International ARTICLES

Extra safety scrutiny planned as virus vaccine worries grow

Extra safety scrutiny planned as virus vaccine worries grow
The poll from The Associated Press-NORC Center for Public Affairs Research found only 46% of Americans want a COVID-19 vaccine and another 29% are unsure.

Extra safety scrutiny planned as virus vaccine worries grow

Retiree checks to rise 1.3% in 2021 amid coronavirus fallout

Retiree checks to rise 1.3% in 2021 amid coronavirus fallout
The COLA affects the personal finances of about 1 in 5 Americans, including Social Security recipients, disabled veterans and federal retirees, some 70 million people in all.

Retiree checks to rise 1.3% in 2021 amid coronavirus fallout

AP-NORC poll: New angst for caregivers in time of COVID-19

AP-NORC poll: New angst for caregivers in time of COVID-19
The Associated Press-NORC Center for Public Affairs Research poll finds that 17% of Americans say they are providing ongoing caregiving, part of an informal volunteer corps.

AP-NORC poll: New angst for caregivers in time of COVID-19

Am I immune to the coronavirus if I’ve already had it?

Am I immune to the coronavirus if I’ve already had it?
Reinfection so far has been rare. The best known example: Researchers in Hong Kong said a man had mild COVID-19 and then months later was infected again but showed no symptoms.

Am I immune to the coronavirus if I’ve already had it?

Antibody drugs are no cure but seem promising for COVID-19

Antibody drugs are no cure but seem promising for COVID-19
Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help it be eliminated. Vaccines mimic an infection to spur antibody production.

Antibody drugs are no cure but seem promising for COVID-19

Lilly seeks emergency use of its antibody drug for COVID-19

Lilly seeks emergency use of its antibody drug for COVID-19
Eli Lilly and Company announced the partial results Wednesday in a news release; they have not yet been published or reviewed by independent scientists.

Lilly seeks emergency use of its antibody drug for COVID-19